Aspirin Better Than Ticlopidine For Stroke Recurrence Prevention In Blacks
This article was originally published in The Tan Sheet
Executive Summary
Aspirin appears to be a "better treatment for aspirin-tolerant black patients with noncardioembolic ischemic stroke" than ticlopidine (Roche's Ticlid) for prevention of recurrent stroke, myocardial infarction and vascular death, according to a recent study